The Alliance for Safe Biologic Medicines was organized to serve as an authoritative resource center of information for the general public, as well as the healthcare and health policy communities, on the issues surrounding biologic medications.

Each state will be considering or introducing legislation to address what an FDA determination on interchangeability will mean for state substitution policies.  While the ultimate goal is to find a balance between producing economical drugs and respecting the drug-discovery process, patient safety should be paramount.

We are particularly concerned about how state laws and regulations will impact the doctor-patient relationship. Doctors and patients should be able to carefully choose the best course of treatment rather than have legislators and regulators decide for them. The path state governments decide to pursue in approving biosimilars should reinforce this principle.

As such, a number of local organizations have joined together to ensure that state biosimilar interchangeability and substitution issues are not implemented in ways that negatively impact patient care or the role of the physician in that process.

Please check back for more information on our membership and activities.

• Archive

  BioOhio Annual Conference 2011

  June 16, 2011

  October 27, 2011 Embassy Suites Dublin Dublin, OH Read More

  June 16, 2011

  BioOhio BioEnterprise Corporation, Cleveland BioStart Edison Biotechnology Institute – Ohio University TechColumbus Office of Governor John Kasich Ohio Department of Health Ohio House of Representatives Ohio State Legislature Ohio State Medical Association Ohio State Senate

  BioOhio – Government Relations Issues

  June 16, 2011

  BioOhio represents and advocates for Ohio’s bioscience community to improve business environment and public funding climate. Alone or in conjunction with partners and members, BioOhio pursues both a proactive and responsive advocacy program. Read More

  BioOhio – Government Relations Issues

  June 16, 2011

  BioOhio represents and advocates for Ohio’s bioscience community to improve business environment and public funding climate. Alone or in conjunction with partners and members, BioOhio pursues both a proactive and responsive advocacy program. Read More

  Ohio: #4 in overall biotechnology strength

  June 16, 2011

  In Business Facilities Magazine’s 2009 Biotechnology Strength Report released last fall, Ohio is once again ranked fourth among all states. California claimed top ranking, followed by Massachusetts, Pennsylvania, and Ohio.  Maryland, Texas, New Jersey, Illinois, Kansas, and North Carolina rounded out the top 10. Read More